These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7930759)

  • 1. Effects of interferon-alpha on a reduced release of interleukin-8 from latently HIV-1-infected monocytic cell line U937 cells.
    Ohashi K; Akazawa R; Kurimoto M
    J Interferon Res; 1994 Jun; 14(3):129-32. PubMed ID: 7930759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced interleukin-8 production is depressed in chronic as opposed to acute human immunodeficiency virus 1 infection of promonocytic cells.
    Tiemessen CT; Martin DJ
    Acta Virol; 2000; 44(3):193-8. PubMed ID: 11155365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus.
    Molina JM; Scadden DT; Byrn R; Dinarello CA; Groopman JE
    J Clin Invest; 1989 Sep; 84(3):733-7. PubMed ID: 2474573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour necrosis factor-alpha increases the sensitivity of human immunodeficiency virus (HIV)-infected monocytic U937 cells to the complement-dependent cytotoxicity of sera from HIV type 1-infected individuals; role of the gp120 protein.
    Szabò B; Locardi C; Lo Presti E; Belardelli F; Benedetto A
    J Gen Virol; 1993 Jul; 74 ( Pt 7)():1271-6. PubMed ID: 8336118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human immunodeficiency virus (HIV)-infected tumor xenografts as an in vivo model for antiviral therapy: role of alpha/beta interferon in restriction of tumor growth in nude mice injected with HIV-infected U937 tumor cells.
    Puddu P; Locardi C; Sestili P; Varano F; Petrini C; Modesti A; Masuelli L; Gresser I; Belardelli F
    J Virol; 1991 May; 65(5):2245-53. PubMed ID: 1901915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective defect of interferon alpha production in human immunodeficiency virus-infected monocytes.
    Gendelman HE; Friedman RM; Joe S; Baca LM; Turpin JA; Dveksler G; Meltzer MS; Dieffenbach C
    J Exp Med; 1990 Nov; 172(5):1433-42. PubMed ID: 2264889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of inflammatory cytokines in placental monocytes of gravidae infected with the human immunodeficiency virus type 1.
    Reuben JM; Turpin JA; Lee BN; Doyle M; Gonik B; Jacobson R; Shearer WT
    J Interferon Cytokine Res; 1996 Nov; 16(11):963-71. PubMed ID: 8938574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of alpha interferon production with natural killer cell lysis of U937 cells infected with human immunodeficiency virus.
    Rappocciolo G; Toso JF; Torpey DJ; Gupta P; Rinaldo CR
    J Clin Microbiol; 1989 Jan; 27(1):41-8. PubMed ID: 2913035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cytokines on HIV release and IL-2 receptor alpha expression in monocytic cell lines.
    Tsunetsugu-Yokota Y; Honda M
    J Acquir Immune Defic Syndr (1988); 1990; 3(5):511-6. PubMed ID: 1691289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-10 enhances human immunodeficiency virus type 1 expression in a chronically infected promonocytic cell line (U1) by a tumor necrosis factor alpha-independent mechanism.
    Angel JB; Saget BM; Wang MZ; Wang A; Dinarello CA; Skolnik PR
    J Interferon Cytokine Res; 1995 Jun; 15(6):575-84. PubMed ID: 7553227
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental gene therapy: the transfer of Tat-inducible interferon genes protects human cells against HIV-1 challenge in vitro and in vivo in severe combined immunodeficient mice.
    Sanhadji K; Leissner P; Firouzi R; Pelloquin F; Kehrli L; Marigliano M; Calenda V; Ottmann M; Tardy JC; Mehtali M; Touraine JL
    AIDS; 1997 Jul; 11(8):977-86. PubMed ID: 9223731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type I interferon responses are impaired in latently HIV infected cells.
    Ranganath N; Sandstrom TS; Fadel S; Côté SC; Angel JB
    Retrovirology; 2016 Sep; 13(1):66. PubMed ID: 27613235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.
    Shirazi Y; Pitha PM
    J Hum Virol; 1998; 1(2):69-76. PubMed ID: 10195234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-6 augments Fc IgE receptor (Fc epsilon RII/CD23) expression on human monoblastic/monocytic cell lines U937, THP-1, and Mono-Mac-6 but not on blood monocytes. Regulatory effects of IL-4 and IFN-gamma.
    Willheim M; Gessl A; Berger R; Schedle A; Luger T; Föster O; Boltz-Nitulescu G
    J Immunol; 1991 Sep; 147(6):1837-42. PubMed ID: 1832425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of interleukin-1 beta RNA in monocytic cells infected with human immunodeficiency virus-1.
    Yamato K; el-Hajjaoui Z; Simon K; Koeffler HP
    J Clin Invest; 1990 Oct; 86(4):1109-14. PubMed ID: 1698820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-8 fails to induce human immunodeficiency virus-1 expression in chronically infected promonocytic U1 cells but differentially modulates induction by proinflammatory cytokines.
    Tiemessen CT; Kilroe B; Martin DJ
    Immunology; 2000 Sep; 101(1):140-6. PubMed ID: 11012765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of a tac inhibitory activity by adherent cells of HIV-infected subjects at different clinical stages.
    Ammar A; Bertoli AM; Sahraoui Y; Perraki M; Tsilivakos V; Meyer P; Rozenbaum W; Jasmin C; Georgoulias V
    J Acquir Immune Defic Syndr (1988); 1991; 4(12):1208-17. PubMed ID: 1941527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected U1 cells by a long terminal repeat independent post-transcriptional mechanism.
    Kinter AL; Biswas P; Alfano M; Justement JS; Mantelli B; Rizzi C; Gatti AR; Vicenzi E; Bressler P; Poli G
    Mol Med; 2001 Oct; 7(10):668-78. PubMed ID: 11713366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.